Journals
Publish with us
Publishing partnerships
About us
Blog
Journal of Oncology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Journal of Oncology
/
2022
/
Article
/
Tab 4
/
Research Article
Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial
Table 4
Comparison of OS (months).
Events
Median
0.95 LCL
0.95 UCL
Control group (
n
= 22)
14
27.1
20.7
NA
Study group (
n
= 22)
7
NA
NA
NA
HR (95% CI)
2.56 (1.081–6.06)
0.035